Directory
Portfolio companies.
34,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
4
currently held
Exits tracked
0
hand-checked
Sectors covered
1
across the portfolio
Countries covered
1
from every market
Latest activity
Capital Event · capital-cancellation-shares · Capital structure change
capitalCapital Event · capital-cancellation-shares · Capital structure change
capitalCapital Event · capital-cancellation-shares · Capital structure change
capitalCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway
adminBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board
admin4 companies matching
| Company | Sector | Geo | Investor | Entry | Hold | Status | Buyer | MOIC | |
|---|---|---|---|---|---|---|---|---|---|
Provectus Algae Hitachi Ventures Fund II | Hitachi Ventures | 2021 | 5yr | Active | – | – | |||
AdvanCell2 periods Abingworth Bioventures 8 | Abingworth | 2025 | 1yr | Active | – | – | |||
Atisama Therapeutics IP Group (Evergreen) | IP Group | 2021 | 5yr | Active | – | – | |||
Opthea Abingworth Clinical Co-Development Fund 2 | Abingworth | 2022 | 4yr | Active | – | – |
Provectus Algae
Hitachi Ventures Fund II
Australia
Sector
Biotech
InvestorHitachi Ventures
Entry
2021
Hold
5yr
AdvanCell
Abingworth Bioventures 8
Australia
Sector
Biotech
InvestorAbingworth
Entry
2025
Hold
1yr
Owners
2
Atisama Therapeutics
IP Group (Evergreen)
Australia
Sector
Biotech
InvestorIP Group
Entry
2021
Hold
5yr
Opthea
Abingworth Clinical Co-Development Fund 2
Australia
Sector
Biotech
InvestorAbingworth
Entry
2022
Hold
4yr